NCT03817112View on ClinicalTrials.gov

Effect of Dexmedetomidine and Propofol on Regional Cerebral Tissue Oxygen Saturation

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 15, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

January 21, 2019

Conditions
Regional Cerebral Tissue Oxygen Saturation
Interventions
DRUG

Dexmedetomidine Hydrochloride 0.1 MG/ML

Dexmedetomidine Hydrochloride 0.1 MG/ML infusion at 0.2-0.7 mcg/kg/min

DRUG

Propofol 10 MG/ML

Propofol 10 MG/ML infusion at 0.3 -4 mg/kg/h

Trial Locations (1)

Unknown

Ain Shams Cardiothoracic hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT03817112 - Effect of Dexmedetomidine and Propofol on Regional Cerebral Tissue Oxygen Saturation | Biotech Hunter | Biotech Hunter